JACK GRAY: Open Payments
NPI 1295708519 · NORMAN, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,002 in 32 payments from 13 companies in 2025. Trend: 2023 $1,667 · 2024 $1,757 · 2025 $1,002
Food & beverage: $1,002
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 7 | $233 |
| Otsuka America Pharmaceutical, Inc. | 7 | $153 |
| Teva Pharmaceuticals USA, Inc. | 1 | $117 |
| Supernus Pharmaceuticals, Inc. | 1 | $116 |
| ABBVIE INC. | 2 | $104 |
| Janssen Pharmaceuticals, Inc | 4 | $73 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $72 |
| Axsome Therapeutics, Inc. | 1 | $37 |
| Noven Therapeutics, LLC | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
Products named: COBENFY, REXULTI, AUSTEDO XR, Qelbree, VRAYLAR, SPRAVATO, CAPLYTA, Auvelity.
Industry payments across OK — which companies pay providers there.
